Bicycle Therapeutics plc

NasdaqGS:BCYC Stock Report

Mkt Cap: US$829.2m

Bicycle Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average management tenure

CEO

Kevin Lee (53 yo)

7.33yrs

Tenure

US$4,465,319

Compensation

Dr. Kevin Lee, M.B.A., Ph D., has been Chief Executive Officer of Bicycle Therapeutics plc since September 2015. Dr. Lee joined Bicycle Therapeutics from Pfizer where he served as Senior Vice President and...

CEO Compensation Analysis

How has Kevin Lee's remuneration changed compared to Bicycle Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$101m

Jun 30 2022n/an/a

-US$87m

Mar 31 2022n/an/a

-US$78m

Dec 31 2021US$4mUS$677k

-US$67m

Sep 30 2021n/an/a

-US$66m

Jun 30 2021n/an/a

-US$62m

Mar 31 2021n/an/a

-US$56m

Dec 31 2020US$3mUS$592k

-US$51m

Sep 30 2020n/an/a

-US$38m

Jun 30 2020n/an/a

-US$37m

Mar 31 2020n/an/a

-US$35m

Dec 31 2019US$4mUS$517k

-US$31m

Sep 30 2019n/an/a

-US$33m

Jun 30 2019n/an/a

-US$31m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018US$818kUS$386k

-US$22m

Compensation vs Market: Kevin's total compensation ($USD4.47M) is about average for companies of similar size in the US market ($USD3.82M).

Compensation vs Earnings: Kevin's compensation has increased whilst the company is unprofitable.

Leadership Team

NamePositionTenureCompensationOwnership
Kevin Lee
CEO & Executive Director7.33yrsUS$4.47m0.78%
$ 6.5m
Lee Kalowski
President & CFO5.5yrsUS$1.70m0.0065%
$ 54.1k
Gregory Winter
Co-Founderno dataUS$243.50k0.57%
$ 4.7m
Michael Skynner
Chief Technology Officer1yrUS$1.79m0.15%
$ 1.2m
Christian Heinis
Scientific Founderno datano datano data
Alistair Milnes
Chief Operating Officer1yrno data0.032%
$ 263.4k
Nicholas Keen
Chief Scientific Officer6yrsno data0.059%
$ 486.3k
David Borah
Vice President of Capital Markets & Investor Relationsno datano datano data
Zafar Qadir
General Counsel2.75yrsno datano data
Gillian Langford
Head of Clinical and Project Management6.67yrsno datano data
Phil Jeffrey
Senior VP of Pre-Clinical Development4.17yrsno datano data
Nigel Crockett
Chief Business Officer3.33yrsUS$1.40m0.0066%
$ 54.4k

4.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: BCYC's management team is considered experienced (4.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kevin Lee
CEO & Executive Director7.33yrsUS$4.47m0.78%
$ 6.5m
Gregory Winter
Co-Founderno dataUS$243.50k0.57%
$ 4.7m
Keith Peters
Chairman of Scientific Advisory Board4.67yrsno datano data
Pierre Legault
Non-Executive Chairman3.83yrsUS$616.00k0.034%
$ 279.3k
Veronica Geraldine Jordan
Independent Non-Executive Director3.25yrsUS$261.85k0.017%
$ 139.6k
Richard Kender
Independent Non-Executive Director3.5yrsUS$300.00k0.017%
$ 139.6k
Garret FitzGerald
Member of Scientific Advisory Board2.25yrsno datano data
Caetano Reis e Sousa
Member of Scientific Advisory Board2.25yrsno datano data
Janice Bourque
Independent Non-Executive Director3.5yrsUS$266.50k0.017%
$ 139.6k
Geoffrey Shapiro
Member of Scientific Advisory Board4.67yrsno datano data
Charles Swanton
Member of Scientific Advisory Board2.25yrsno datano data
Jane Grogan
Member of Scientific Advisory Board2.25yrsno datano data

3.5yrs

Average Tenure

65yo

Average Age

Experienced Board: BCYC's board of directors are considered experienced (3.5 years average tenure).